J&J beats 3Q net views, hikes 2020 forecast, but shares fall
Despite the coronavirus pandemic hurting sales of most of its products, Johnson & Johnson boosted revenue slightly and doubled its third-quarter profit, mainly due to a huge litigation charge in the year-ago quarter.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
